All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • SPY002SPY002-091Phase 22 trials

    Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis

  • SPY002-072SPY072Phase 22 trials

    Spyre Therapeutics, Inc. · Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis

  • SPY003SPY003-207Phase 22 trials

    Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis

  • SRSD107Phase 22 trials

    Sirius Therapeutics Co., Ltd. · Venous Thromboembolism, Coronary Artery Disease (CAD), Peripheral Arterial Disease

  • SSGJ-612HER2-targeted antibodyPhase 22 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · Locally Advanced (Unresectable) or Metastatic Solid Tumors, Metastatic Breast Cancer

  • SSGJ-705Phase 22 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · Locally Advanced, Recurrent or Metastatic Malignancies, Locally Advanced (Unresectable) or Metastatic Solid Tumors

  • SSS17Phase 22 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · Postoperative Anemia, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee

  • STAR0602InvikafuspPhase 22 trials

    Marengo Therapeutics, Inc. · Triple Negative Locally Advanced Non-resectable Breast Cancer, HR+, HER2-, Advanced Breast Cancer, Advanced Solid Tumors

  • STL303Phase 22 trials

    Sitala Bio LTD · IgAN, Geographic Atrophy

  • STP938Phase 22 trials

    Step Pharma, SAS · Lymphoma, B-Cell, Lymphoma, T-Cell, Essential Thrombocythaemia

  • STSP-0902Phase 22 trials

    Staidson (Beijing) Biopharmaceuticals Co., Ltd · Neurotrophic Keratitis, Oligozoospermia and/or Asthenozoospermia

  • SunobinopV117957Phase 22 trials

    Knoa Pharma LLC · Alcohol Use Disorder

  • Sutetinib MaleatePhase 22 trials

    Teligene US · Non-small Cell Lung Cancer

  • SYH2051Phase 22 trials

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors, Breast Cancer

  • SYH2069group 1, group 2Phase 22 trials

    CSPC Ouyi Pharmaceutical Co., Ltd. · T2DM (Type 2 Diabetes Mellitus), Overweight or Obesity

  • SYH2072Phase 22 trials

    InnovStone Therapeutics Limited · Uncontrolled Hypertension, Resistant Hypertension, Primary Aldosteronism

  • SYS6041Phase 22 trials

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Ovarian Cancer, Recurrent Ovarian Cancer, Advanced Solid Tumors

  • TCC1727Phase 22 trials

    Beijing Tide Pharmaceutical Co., Ltd · Patients with Advanced Solid Tumors, Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer)

  • TE-8105 MADPhase 22 trials

    Immunwork, Inc. · Overweight and Obesity

  • TebapivatAG-946Phase 22 trials

    Agios Pharmaceuticals, Inc. · Myelodysplastic Syndromes, Sickle Cell Disease

  • Test Product HY07121HY0007-101Phase 22 trials

    Sichuan Huiyu Pharmaceutical Co., Ltd · Safety, Tolerability, Efficacy

  • TEV-56286EmrusolminPhase 22 trials

    Teva · Multiple System Atrophy

  • TibulizumabZB-106Phase 22 trials

    Zura Bio Inc · Hidradenitis Suppurativa (HS), Systemic Sclerosis (SSc), Scleroderma

  • TifeglipronRO7795081, CT-996Phase 22 trials

    Roche (Genentech) · Type 2 Diabetes Mellitus, Obesity or Overweight

  • Tigilanol TiglateEBC-46Phase 22 trials

    QBiotics Group Limited · Soft Tissue Sarcoma, Head and Neck Cancer

  • TNO155Phase 22 trials

    Novartis · Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation, KRAS G12C Mutant Solid Tumors

  • TNP-2092rifaquizinonePhase 22 trials

    TenNor Therapeutics (Zhongshan) Limited · Prosthetic Joint Infection (PJI), Periprosthetic Joint Infection (PJI)

  • TollB-001Phase 22 trials

    Toll Biotech Co. Ltd. (Beijing) · Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc)

  • TonlamarsenPhase 22 trials

    Kardigan, Inc. · Hypertension, Acute Severe Hypertension, Hypertensive Emergency

  • TQB2916Phase 22 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Soft Tissue Sarcoma, Melanoma, Pancreatic Cancer

  • TQB3702Phase 22 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · B-cell Lymphoma, Systemic Lupus Erythematosus

  • TQB6411Phase 22 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Advanced Lung Cancer, Esophageal Cancer

  • TQC2938Phase 22 trials

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Chronic Obstructive Pulmonary Disease, Seasonal Allergic Rhinitis

  • TRK-950Phase 22 trials

    Toray Industries, Inc · Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

  • TrosunilimabABBV-382Phase 22 trials

    AbbVie · Crohn's Disease, Ulcerative Colitis

  • TRS005Phase 22 trials

    Zhejiang Teruisi Pharmaceutical Inc. · CD20-positive Diffuse Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL)

  • TRX-100Phase 22 trials

    Traws Pharma, Inc. · Influenza

  • TS23Phase 22 trials

    Translational Sciences, Inc. · Ischemic Stroke, Pulmonary Embolism

  • TST001Phase 22 trials

    Transcenta Therapeutics (Hangzhou) Co., Ltd. · Advanced Cancer, Gastric Cancer, Gastroesophageal-junction Cancer

  • TTAX03Phase 22 trials

    BioTissue Holdings, Inc · Knee Osteoarthritis, Knee Pain Chronic, Knee Arthritis

  • TTI-0102cysteamine-pantetheine disulfidePhase 22 trials

    Thiogenesis Therapeutics, Inc. · Nephropathic Cystinosis, Cystinosis, MELAS Syndrome

  • TTI-101Phase 22 trials

    Tvardi Therapeutics, Incorporated · Hepatocellular Carcinoma, Idiopathic Pulmonary Fibrosis

  • TU2218Phase 22 trials

    TiumBio Co., Ltd. · Advanced Solid Tumor, Solid Tumor, Biliary Tract Cancer

  • TX000045Phase 22 trials

    Tectonic Therapeutic · Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction, Hypertension, Pulmonary

  • TYK-00540Phase 22 trials

    TYK Medicines, Inc · mCRPC, HR-positive, HER2-negative Advanced Breast Cancer

  • VEGF antibodyPhase 22 trials

    Lepu Biopharma Co., Ltd. · Hepatocellular Carcinoma, Advanced Colorectal Cancer

  • VG2025Phase 22 trials

    Virogin Biotech Ltd. · Intrahepatic Cholangiocarcinoma, Colorectal Cancer With Hepatic Metastases

  • VHB937Phase 22 trials

    Novartis · Amyotrophic Lateral Sclerosis (ALS), Alzheimer's Disease

  • vilamakitugXB2001, NatrunixPhase 22 trials

    XBiotech, Inc. · Axial Spondyloarthritis, Ankylosing Spondylitis, r-axSpA

  • vilobelimabPhase 22 trials

    PPD Development, LP · Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome)

NewerPage 40 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.